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Severe sepsis and septic shock are common and fre-
quently fatal problem in I.C.U. Recent therapeutic
advances to routine clinical practice has proven contro-
versial, because of their pleiotropic effects related to
many pathophysiological determinants of sepsis. Statin
therapy could be the next step in the search for adjuvant
therapy. This study was done to evaluate chronic statin
therapy on outcome of patients with sepsis and septic
shock in I.C.U
Methods
We compared patients with severe sepsis and septic
shock. Two groups were identified, group A, patients
didn`t receive statin before or during their I.C.U man-
agement. Group B, patients with ongoing statin therapy
before admission and continued during I.C.U therapy.
The primary end point was the number of organ failure
free days, hemodynamic failure free days and organ dys-
function free days up to day 14. Secondary endpoints
included hospital mortality and safety.
Results
Patients in whom chronic statin therapy had been contin-
ued in the I.C.U (n = 45) had significantly more organ
failure free days 12(5-15), organ dysfunction free days
10(2-13), hemodynamic failure free days 13(9-14) as
compared to others non statin group(n = 33) with organ
failure fee days 5(0-11), organ dysfunction free days 2(0-
10), and hemodynamic failure free days 9(6-12). The
need for increased mortality and hospital length of stay
were comparable in the two groups.
Conclusions
Chronic statin therapy in I.C.U septic patients was asso-
ciated with reduction in the severity of organ failure and
hemodynamic failure with no improvement in hospital
mortality and length of stay.
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